Skip to main content

Larson Financial Group LLC

Position in NBIX — Neurocrine Biosciences Inc

CIK 1731061 ST LOUIS, MO

Position in NBIX

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$258,877
+$55,734 QoQ
Shares Held
1,536
-0.4% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#563
of 772 holders
Holding Since
Jun 2022
15 quarters on record
Voting authority Sole 0% Shared 0% None 100%

Common Shares in NBIX Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Jun 30, 2026

Larson Financial Group LLC holds $2,625,097 across 43 Drug Manufacturers - Specialty & Generic names. NBIX ranks #2 (9.9% of the industry book) .

# Ticker Company Shares Value (USD) Open
2 NBIX
Neurocrine Biosciences Inc
This page
1,536 $258,877

All Filings in NBIX

Export CSV
15 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $258,877 1,536
2026-03-31 $203,143 1,542
2025-12-31 $142,539 1,005
2025-09-30 $106,267 757
2025-06-30 $89,239 710
2025-03-31 $44,240 400
2024-12-31 $192,874 1,413
2024-09-30 $161,423 1,401
2024-06-30 $260,609 1,893
2024-03-31 $305,216 2,213
2023-12-31 $297,382 2,257
2023-09-30 $1,237 11
2022-12-31 $278,414 2,331
2022-09-30 $206,047 1,940
2022-06-30 $177,218 1,818